Catalyst Wire Dossier Catalyst Wire Dossier

MAU868

MAU868 · Vera Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAU868, covering 2023-05-24 to 2023-05-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients [Phase 2]

See pricing